Jump to main content.


Pesticide Registration Improvement Extension Act (PRIA 3)
Fee Determination Decision Tree

Decision Tree Resources:

Below is the fee for your selected Fee Category for Fiscal Years 2014/2015

Action Code Description FY14/15
Fee
Decision Time
(months)
B677 New end-use non-food animal product with submission of two or more target animal safety studies; includes data and/or waivers of data for only:
• product chemistry and/or
• acute toxicity and/or
• public health pest efficacy and/or
• animal safety studies and/or
• child resistant packaging (2)
$ 8,400 10

Do you plan to request either of the following types of waivers?


50% waiver You pay ---->>>>> $ 4,200  
75% waiver You pay ---->>>>> $ 2,100  

To pay the fee shown above, go to http://www.pay.gov and follow the instructions.

How to submit your application directly to EPA.


Action Code Interpretation
An application for registration of a new microbial or biochemical pesticide end-use animal product that is not substantially similar or identical in its uses and formulation to a product currently registered. For example, spot-on and flea collars products are generally labeled species specific, in that a product is labeled for dogs or cats, but not generally both, while shampoos and sprays may be labeled for both species (dogs and cats). All applications require the following:
  • A data matrix is required with the application.
  • Product chemistry data (Group A and B) and CSF. In some cases product chemistry data can be satisfied as outlined in Pesticide Registration Notice 98-1. If the source of the active ingredient is not registered in this application; the decision review time line will be the longest of the associated application (see timeline for B672).
  • All of the inerts used in the product must be either approved or pending with the Agency for the applicable uses. In those cases where the product relies upon a pending inert clearance, the new companion animal studies must be conducted with the pending inert in the tested product as it is intended to be marketed and sold as the end use product.
  • Acute toxicity, public health pest efficacy, child resistant packaging data, companion animal safety data and/or requirements must be addressed by using: 1) the cite-all method, or 2) selective data citation which includes submitting required data. A rationale for a waiver or bridging of these data falls within this category.
  • Which companion animal safety studies are required is based upon the specific label claims in the proposed label. For example, if the proposed end use product label claim is to - use the product on 12 week old kittens weighing ≥ 3 lbs and breeding cats, then two companion animal studies are required: the first on using kittens ≥ 12 weeks of age and weighing at least 3 lbs., and a second study on pregnant and nursing adult cats. Each of these studies must demonstrate an adequate margin of safety.
  • Proposed label for the end use product.

An application for a new end-use product using a source of active ingredient that is not yet registered but has an application pending with the Agency for review, will be considered an application for a new product with an unregistered source of an active ingredient.


     Go to the start of the Decision Tree

Publications | Glossary | A-Z Index | Jobs


Local Navigation


Jump to main content.